Skip to main content
Premium Trial:

Request an Annual Quote

The Funds It Needs

Smaller scientific research budgets lead to less data being generated by scientists, not the "romantic ideas of a creative genius alone in a lab, struggling against the odds," writes Oxford University's Mark Stokes in the Guardian. Stokes, a neuroscientist, notes that a number of experiments in his field have been underpowered.

"Insufficient data inevitably comes down to a question of funding. Scientists love data, and they especially love lots of data," he writes. "But funding is always limited and expectations are always high — there are strong incentives to publish more for less."

However, Stokes says that increasing funding — as brain-mapping efforts in the US and Europe plan to do — is only part of the issue. The other part is the notion that doing science on the cheap is cost effective, he says. Poorly funded studies may be underpowered and full of false-positive results that could lead other researchers astray. "So yes, science needs more funding, but we also need to rethink how the available funds are allocated," Stokes writes. "If there is a genuine commitment to funding a particular experiment, then it is essential that enough money is allocated for that experiment to be carried out properly."

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.